CÔNG TY CỔ PHẦN CÔNG NGHỆ SINH HỌC DƯỢC NANOGEN

Company Profile: Nanogen Pharmaceutical Biotechnology Joint Stock Company

Company Type: Manufacturer

Introduction:

Nanogen Pharmaceutical Biotechnology Joint Stock Company, officially known as CÔNG TY CỔ PHẦN CÔNG NGHỆ SINH HỌC DƯỢC NANOGEN, is a prominent Vietnamese enterprise in the field of biotechnology and pharmaceuticals. Established as a pioneer in its sector, Nanogen focuses on the research, development, and manufacturing of high-tech biological products.

The company specializes in recombinant protein technology, producing a diverse range of pharmaceutical products, including vaccines, biopharmaceuticals, and diagnostic kits. Nanogen aims to contribute significantly to Vietnam's healthcare independence by providing high-quality, domestically produced, and affordable medical solutions, thereby reducing the country's reliance on imported drugs.

Nanogen operates advanced research and development facilities alongside modern manufacturing plants that adhere to international quality standards. It gained significant public attention, particularly during the COVID-19 pandemic, due to its efforts in developing a domestic vaccine candidate, NanoCovax, which highlighted its substantial capabilities in biotechnological innovation and large-scale production.

Nanogen is committed to advancing scientific research and technological application to deliver innovative healthcare products for the Vietnamese population and beyond.

Here are some of the products manufactured or sold by the Vietnamese company CÔNG TY CỔ PHẦN CÔNG NGHỆ SINH HỌC DƯỢC NANOGEN:

* Nanocovax vaccine (COVID-19 vaccine)

* Recombinant human Erythropoietin (EPO)

* Filgrastim

* Pegfilgrastim

* Other biopharmaceutical products and biosimilars.